Arphra/Issuer/RMD

RMD

ResMed Inc.

HealthcareMedical - DevicesUSUSD

$190.57

+1.11%Live · FMPMay 29, 2026

AI Brief

Market cap

$27.64B

52w range

190.38 – 293.81

P / E

—

EPS

—

Volume

3.53M

Revenue · FY

$5.15B

+9.84% YoY

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

$5.97M

10 txns

Net flow

−$5.97M

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$207.27

Change

-15.06%

Period high

$293.73

Period low

$205.02

Period start

$244.032025-06-02

Through 2026-05-04

Peers

Price change · trailing returns

Live · FMP

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
-6.32%	-8.85%	-7.05%	-25.63%	-23.27%	-20.88%	-21.91%	-12.86%	-7.60%	+222.07%	+28263.70%

Aftermarket

Live · FMP

Jun 01, 08:43 AM

Last trade

$190.60

1,336 sh

Bid

$190.57

6 sh

Ask

$194.99

16 sh

Spread

$4.420

Sector & industry today

Live · FMP

Sectors

Technology
+0.21%
Basic Materials
+0.15%
Financial Services
-0.43%
Industrials
-0.48%
Energy
-0.58%
Consumer Defensive
-0.79%
Consumer Cyclical
-0.85%
Real Estate
-0.98%
Healthcare
-1.37%
Communication Services
-1.47%
Utilities
-2.07%

Top industries (issuer's industry highlighted)

Medical - Devices
-1.43%
Software - Infrastructure
+6.80%
Coal
-6.27%
Information Technology Services
+6.00%
Medical - Healthcare Information Services
+5.23%
Other Precious Metals
+3.84%
Broadcasting
-3.48%
Silver
+2.89%
Renewable Utilities
-2.75%
Software - Application
+2.71%
Travel Lodging
-2.70%
Internet Content & Information
-2.61%

Fair value

Football field →

Weighted blend

$379.90

+99.35% vs spot

Recommendation

Strong Buy

18 of 19 methods

Method spread

5bull11bear

±5% threshold

Analyst PT consensus: $281.29 (+47.60%)

Total assets

$8.17B

Total debt

$851.81M

Cash & equiv

$1.21B

Operating CF

$1.75B

Free cash flow

$1.66B

Buybacks

-$300.03M

Analyst view

DB · price_targets + analyst_grades

Consensus target

$281.29

+47.60% upside

Low

$225.00

Median

$275.00

High

$345.00

Recent actions

0 ↑0 ↓8 hold

May 01, 2026
Apr 01, 2026
Mar 01, 2026
Feb 01, 2026
Jan 01, 2026

News

DB · news_items

RMD Stock Down Despite Q3 Earnings & Revenue Beat, Margins Rise
zacks.com·May 01, 2026

Recent quarters

All financials →

Period	Revenue	Net income	EPS
Q3 Mar 2026	$1.43B	$398.73M	$2.71
Q2 Dec 2025	$1.42B	$392.59M	$2.68
Q1 Sep 2025	$1.34B	$348.54M	$2.37
Q4 Jun 2025	$1.35B	$379.71M	$2.58
Q3 Mar 2025	$1.29B	$365.04M	$2.48
Q2 Dec 2024	$1.28B	$344.62M	$2.34

Recent insiders

All →

Insider	Action	Shares	Value	Date
Farrell Michael J. director, officer: Chairman and CEO	Sell	4,991	$1.13M	Apr 07, 2026
Sandercock Brett officer: Chief Financial Officer	Sell	1,000	$224.31K	Apr 01, 2026
FARRELL PETER C director	Sell	2,000	$450K	Apr 01, 2026
Farrell Michael J. director, officer: Chairman and CEO	Sell	4,991	$1.25M	Mar 09, 2026
FARRELL PETER C director	Sell	2,000	$520.44K	Mar 04, 2026
Sandercock Brett officer: Chief Financial Officer	Sell	1,000	$254.3K	Mar 02, 2026

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2025	$5.15B	$1.69B	$1.4B	$9.51	+27.22%
FY 2024	$4.69B	$1.32B	$1.02B	$6.92	+21.79%
FY 2023	$4.22B	$1.13B	$897.56M	$6.09	+21.25%
FY 2022	$3.58B	$1B	$779.44M	$5.30	+21.78%
FY 2021	$3.2B	$903.68M	$474.51M	$3.24	+14.84%